A new study of patients treated with long-duration dual-antiplatelet therapies after the placement of drug-eluting stents shows a lower rate of heart attack but a higher risk for major bleeding events.
Patients treated with long-duration anti-platelet therapies after the placement of a drug-eluting stent showed lower rates of heart attack but higher rates of major bleeding events and a slight increase in mortality, according to a new study released today.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1FC7OfM
Cap comentari:
Publica un comentari a l'entrada